Adeno-Associated Virus-Mediated Dorsal Root Ganglion Toxicity in the New Zealand White Rabbit

• Published in: Toxicologic pathology 2024-01, Vol.52 (1), p.35-54
• Main Authors: Tien, Eric, Grubor, Branka, Kirkland, Melissa, Chan, Su Jing, van der Munnik, Nick, Xu, Wenlong, Henry, Kate, Hamann, Stefan, Wei, Cong, Lee, Wan-Hung, Gianni, Davide, Brennecke, Ashton, Nambiar, Kalyani, Chen, Jeron, Liu, Bin, Shen, Shen, Tremblay, Claudine, Plowey, Edward D., Trapa, Patrick, Fikes, James, Suh, Junghae, Morris, Dale
• Format: Article
• Language: English
• ISSN: 0192-6233; 1533-1601
• DOI: 10.1177/01926233241229808

Recombinant adeno-associated virus (AAV)-mediated degeneration of sensory neurons in the dorsal root ganglia (DRG) and trigeminal ganglia (TG) has been observed in non-human primates (NHPs) following intravenous (IV) and intrathecal (IT) delivery. Administration of recombinant AAV encoding a human protein transgene via a single intra-cisterna magna (ICM) injection in New Zealand white rabbits resulted in histopathology changes very similar to NHPs: mononuclear cell infiltration, degeneration/necrosis of sensory neurons, and nerve fiber degeneration of sensory tracts in the spinal cord and of multiple nerves. AAV-associated clinical signs and incidence/severity of histologic findings indicated that rabbits were equally or more sensitive than NHPs to sensory neuron damage. Another study using human and rabbit transgene constructs of the same protein demonstrated comparable changes suggesting that the effects are not an immune response to the non-self protein transgene. Rabbit has not been characterized as a species for general toxicity testing of AAV gene therapies, but these studies suggest that it may be an alternative model to investigate mechanisms of AAV-mediated neurotoxicity and test novel AAV designs mitigating these adverse effects.